MTOR and colorectal carcinoma: On the other hand, considering the impact of PI3K/AKT/mTOR pathway activation on interactions in the CRC TME, affecting the increased activity of extracellular matrix proteases, this observation requires verification in studies involving a larger group of patients with PIK3CA-mutant tumors [29].